Skip to main content
Livermore
Livermore
ZHEN

Perigon Wealth Management, LLC

SEC CIK
0001575239
Latest filing
Aug 7, 2026

FDMT holding history

4D Molecular Therapeutics, Inc. in every 13F filed by Perigon Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings

Shares (Q2 2026)
146,185
Value
$1.94M
% of portfolio
<0.1%
Quarters held
19
Since Q4 2021
Holdings of FDMT by Perigon Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026146,185$1.94M<0.1%−120.0%ReducedHolders
Q1 2026146,197$1.36M<0.1%+640.0%AddedHolders
Q4 2025146,133$1.10M<0.1%00.0%UnchangedHolders
Q3 2025146,133$1.27M<0.1%00.0%UnchangedHolders
Q2 2025146,133$542.2K<0.1%00.0%UnchangedHolders
Q1 2025146,133$472.0K<0.1%00.0%UnchangedHolders
Q4 2024146,133$683.9K<0.1%−370.0%ReducedHolders
Q3 2024146,170$1.58M<0.1%00.0%UnchangedHolders
Q2 2024146,170$3.07M0.1%+200.0%AddedHolders
Q1 2024146,150$4.66M0.1%−100,000−40.6%ReducedHolders
Q4 2023246,150$4.99M0.2%00.0%UnchangedHolders
Q3 2023246,150$3.13M0.1%+750.0%AddedHolders
Q2 2023246,075$4.45M0.2%00.0%UnchangedHolders
Q1 2023246,075$4.23M0.2%00.0%UnchangedHolders
Q4 2022246,075$5.47M0.3%−4,400−1.8%ReducedHolders
Q3 2022250,475$2.01M0.2%−98,271−28.2%ReducedHolders
Q2 2022348,746$2.43M0.2%−208,729−37.4%ReducedHolders
Q1 2022557,475$8.43M0.6%−209,492−27.3%ReducedHolders
Q4 2021766,967$16.8M1.2%+766,967NewHolders